1. Home
  2. AXGN vs CCCC Comparison

AXGN vs CCCC Comparison

Compare AXGN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • CCCC
  • Stock Information
  • Founded
  • AXGN N/A
  • CCCC 2015
  • Country
  • AXGN United States
  • CCCC United States
  • Employees
  • AXGN N/A
  • CCCC N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXGN Health Care
  • CCCC Health Care
  • Exchange
  • AXGN Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • AXGN 577.0M
  • CCCC 175.1M
  • IPO Year
  • AXGN N/A
  • CCCC 2020
  • Fundamental
  • Price
  • AXGN $16.77
  • CCCC $3.42
  • Analyst Decision
  • AXGN Strong Buy
  • CCCC Strong Buy
  • Analyst Count
  • AXGN 5
  • CCCC 3
  • Target Price
  • AXGN $26.00
  • CCCC $8.67
  • AVG Volume (30 Days)
  • AXGN 1.1M
  • CCCC 1.4M
  • Earning Date
  • AXGN 11-06-2025
  • CCCC 10-30-2025
  • Dividend Yield
  • AXGN N/A
  • CCCC N/A
  • EPS Growth
  • AXGN N/A
  • CCCC N/A
  • EPS
  • AXGN N/A
  • CCCC N/A
  • Revenue
  • AXGN $203,271,000.00
  • CCCC $34,240,000.00
  • Revenue This Year
  • AXGN $19.65
  • CCCC N/A
  • Revenue Next Year
  • AXGN $15.84
  • CCCC N/A
  • P/E Ratio
  • AXGN N/A
  • CCCC N/A
  • Revenue Growth
  • AXGN 17.17
  • CCCC 16.55
  • 52 Week Low
  • AXGN $9.22
  • CCCC $1.09
  • 52 Week High
  • AXGN $21.00
  • CCCC $7.14
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 53.46
  • CCCC 70.84
  • Support Level
  • AXGN N/A
  • CCCC $2.58
  • Resistance Level
  • AXGN $17.00
  • CCCC $3.65
  • Average True Range (ATR)
  • AXGN 0.54
  • CCCC 0.23
  • MACD
  • AXGN -0.64
  • CCCC 0.06
  • Stochastic Oscillator
  • AXGN 98.71
  • CCCC 81.82

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: